Phase-Appropriate Application of Analytical Methods to Monitor Subvisible Particles Across the Biotherapeutic Drug Product Life Cycle

Published

October 30, 2019

Author(s)

Roman Mathaes, Linda Narhi, Andrea Hawe, Anja Matter, Karoline Bechtold-Peters, Sophia Kenrick, Sambit Kar, Olga Laskina, John Carpenter, Richard E. Cavicchi, Ellen Koepf, Neil Lewis, Rukman De Sliva, Dean C. Ripple

Abstract

The phase-appropriate application of analytical methods to characterize, monitor, and control particles is an important aspect of the development of safe and efficacious biotherapeutics. The AAPS Product Attribute and Biological Consequences (PABC) focus group (which has since transformed into an AAPS community) conducted a survey where participating labs rated their method of choice to analyze protein aggregation/particle formation during the different stages of the product life cycle. The survey confirmed that pharmacopeial methods and SEC are the primary methods currently applied in earlier phases of the development to ensure that a product entering clinical trials is safe and efficacious. In later phases, additional techniques are added including those for non-GMP extended characterization for product and process characterization. Finally, only robust, globally-accepted, and stability-indicating methods are used for GMP quality control purposes. This was also consistent with the feedback during a webinar hosted by the group to discuss the survey results. In this white paper, the team shares the results of the survey and provides guidance on selecting phase-appropriate analytical methods and developing a robust particle control strategy.

Citation

The AAPS Journal

Volume

22

Pub Type

Journals

Download Paper

DOI Link

Keywords

biopharmaceutical, biotherapeutic, drug product, life cycle, particle

Citation

Mathaes, R. , Narhi, L. , Hawe, A. , Matter, A. , Bechtold-Peters, K. , Kenrick, S. , Kar, S. , Laskina, O. , Carpenter, J. , Cavicchi, R. , Koepf, E. , Lewis, N. , De Sliva, R. and Ripple, D. (2019), Phase-Appropriate Application of Analytical Methods to Monitor Subvisible Particles Across the Biotherapeutic Drug Product Life Cycle, The AAPS Journal, [online], https://doi.org/10.1208/s12248-019-0384-0 (Accessed April 26, 2024)